Compare IPSC & USAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPSC | USAU |
|---|---|---|
| Founded | 2019 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.1M | 242.1M |
| IPO Year | 2021 | 2020 |
| Metric | IPSC | USAU |
|---|---|---|
| Price | $1.83 | $11.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $4.75 | ★ $26.50 |
| AVG Volume (30 Days) | ★ 972.2K | 178.2K |
| Earning Date | 11-20-2026 | 12-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.30 | 36.11 |
| EPS | N/A | N/A |
| Revenue | ★ $109,164,000.00 | $17,402,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1556.76 | N/A |
| 52 Week Low | $0.44 | $9.96 |
| 52 Week High | $2.97 | $23.72 |
| Indicator | IPSC | USAU |
|---|---|---|
| Relative Strength Index (RSI) | 61.22 | 47.92 |
| Support Level | $1.29 | $10.44 |
| Resistance Level | $2.45 | $16.45 |
| Average True Range (ATR) | 0.15 | 0.62 |
| MACD | 0.04 | 0.18 |
| Stochastic Oscillator | 94.68 | 92.73 |
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
U.S. Gold Corp is a gold, copper and precious metals development and exploration company pursuing exploration opportunities mainly in Wyoming, Nevada and Idaho. It is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada and the Challis Gold Project in Idaho. The company is engaged in the exploration and evaluation of its mineral properties, which is the single operating segment.